HUTCHMED Highlights FRUSICA-2 Registration Trial Data to be Presented at the 2025 ESMO Congress
The fruquintinib and sintilimab combination demonstrated significant PFS improvements in advanced renal…
Celanese Designing the Future at K 2025
New materials and services empower customers to accelerate design innovations, meet complex…
XED Welcomes Back Technology Visionary Mrinal Srivastava as Chief Technology Officer
NEW YORK and MUMBAI, India, Sept. 26, 2025 /PRNewswire/ -- XED is proud…
IndoSpace expands presence with new 66-Acre Park in Maharashtra’s industrial and warehousing hub, Bhiwandi
MUMBAI, India, Sept. 26, 2025 /PRNewswire/ --Â IndoSpace, India's fully integrated supply chain…
C4 Therapeutics Presents Cemsidomide Phase 1 Multiple Myeloma Data Supporting Potential Best-in-Class Profile at the International Myeloma Society Annual Meeting
September 20, 2025 11:00 ET Â | Source: C4 Therapeutics, Inc. Cemsidomide in…
Nxera Pharma and Cancer Research UK Announce First Patient Dosed in Phase 2a Trial of Investigational Cancer Immunotherapy HTL0039732
HTL0039732 (also known as NXE0039732) is Nxera’s novel oral EP4 antagonist being…
Olympism365: Six innovators awarded grants to advance UN SDGs through combination of sport and technology
16 September 2025 – Six recipients have received Tech365 Incubate grants, each…
REGISTRATION OF THE COMBINATION OF SHARES OF DIGITALIST GROUP PLC, AND ADJUSTMENT OF THE MAXIMUM NUMBERS OF SHARES AVAILABLE FOR SUBSCRIPTION UNDER THE COMPANYS CONVERTIBLE LOANS AND 2021 STOCK OPTION PROGRAM, AND THE SUBSCRIPTION PRICES
August 16, 2025 04:05 ET Â | Source: Digitalist Group Oyj REGISTRATION OF…
Anbogen Receives FDA Clearance to Initiate Phase 1/2 Trial of ABT-301 Triplet Therapy for Advanced Colorectal Cancer
TAIPEI, Aug. 4, 2025 /PRNewswire/ -- Anbogen Therapeutics today announced that the…
A23 launches the 3rd season of Rummy Indian Open with a 25 Crore prize pool and a high-stakes finale in Goa
Spanning over two months, RIO is a combination of a tournament and…